Skin & hair

The Deliberate Allergic Reaction That Regrows Hair

Save

Alopecia areata has no cure, but several treatments can coax hair to regrow by calming the immune attack on hair follicles. Topical immunotherapy takes an unusual approach among them: instead of suppressing the immune system, it deliberately sensitizes the scalp to a chemical and keeps triggering a mild allergic reaction there, on the theory that the resulting inflammation draws attention away from the one attacking hair follicles. Here is how that reasoning holds up, what the reaction actually involves, and who it's typically offered to.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What Topical Immunotherapy Actually Does

Topical immunotherapy for alopecia areata involves repeatedly applying a chemical — most often diphenylcyclopropenone (DPCP) — to the scalp to deliberately provoke and then maintain a mild allergic contact dermatitis, the same basic kind of immune reaction a nickel allergy produces on skin 1, and similar in kind to the reaction poison ivy triggers 2. Allergic contact dermatitis is a delayed immune reaction that develops when skin becomes sensitized to a specific substance and reacts with redness, itching, and inflammation on later exposure. Treatment starts with a sensitizing dose to prime the immune system to react to the chemical at all, and once that's established, a clinician adjusts the strength of repeated applications to keep a low-grade reaction going on the scalp over months. Because the chemical isn't approved or manufactured as an off-the-shelf drug product the way most prescriptions are, it's typically compounded and applied in the dermatologist's office rather than sent home for self-application — one of several ways this treatment differs logistically from a cream someone picks up at a pharmacy.

Why Deliberately Causing a Rash Might Regrow Hair

Alopecia areata happens when the immune system mistakenly attacks hair follicles, causing patchy hair loss that can wax and wane unpredictably on its own 3. The working theory behind topical immunotherapy is that a different immune reaction — the induced allergic contact dermatitis — draws immune activity toward the chemical exposure and away from the follicles, though the exact mechanism isn't fully settled even among dermatologists who use it regularly. What is observed clinically is that some people see new hair growth in treated areas over months of ongoing treatment, while others don't respond at all, and there's no reliable way to predict in advance which group any one person will fall into. That uncertainty is worth sitting with honestly rather than glossing over: a treatment built on a working theory rather than a fully mapped mechanism is still a legitimate option, but it's a different kind of conversation than one built on a precisely understood drug action, and it's reasonable to want that distinction spelled out before committing months to a course of visits.

Who This Treatment Is Usually Offered To

Topical immunotherapy tends to enter the conversation for alopecia areata that's more extensive — larger areas of scalp involvement, or hair loss that hasn't responded to simpler options like steroid injections for alopecia areata — rather than as a first approach for a single small patch. Alopecia areata has no cure, and treatments generally aim to promote regrowth rather than guarantee it or prevent future patches, which shapes expectations before starting any option, this one included 3. Because the treatment requires regular clinic visits over an extended period, it also tends to be offered to people prepared for that kind of ongoing commitment rather than a quick fix. Children are sometimes considered for topical immunotherapy too, since alopecia areata isn't limited to adults, though a family weighing it for a child has an extra layer to think through: a school-age child tolerating a visibly irritated, itchy scalp for months is a different practical question than an adult making the same choice for themselves.

What the Skin Goes Through During Treatment

The scalp reaction topical immunotherapy relies on looks and feels like an allergic contact dermatitis anywhere else on the body: redness, itching, scaling, and sometimes weeping or crusting in the treated area, the same features seen with a nickel allergy or a reaction to poison ivy, just deliberately induced and kept going rather than something to be treated away 12. Clinicians adjust the concentration applied at each visit specifically to keep that reaction at a tolerable, low-grade level rather than letting it become severe, since a reaction that's too intense doesn't help and is simply harder to live with day to day.

How This Fits Alongside Other Alopecia Areata Treatments

Topical immunotherapy is one of several alopecia areata treatment options, and it isn't the newest one: oral JAK inhibitors, taken as a pill rather than applied to the scalp, have more recently been shown in large randomized trials to regrow hair in a meaningful share of adults with severe disease 4. That's a fundamentally different approach — dampening immune activity throughout the body rather than provoking a local skin reaction — and the two aren't typically framed as a strict either-or; the choice often comes down to how extensive the hair loss is, what's already been tried, and how someone weighs a daily pill against an ongoing scalp reaction and regular clinic visits. A systemic pill also comes with its own monitoring requirements precisely because it works throughout the body rather than on one patch of skin, which is a genuinely different tradeoff than a localized scalp treatment, not simply a more convenient version of the same idea.

Alopecia Areata Isn't the Same as Pattern Hair Loss

It's worth being clear about what topical immunotherapy is and isn't for: alopecia areata is an autoimmune condition causing patchy loss, while androgenetic (pattern) hair loss is a separate, more gradual process linked to genetics and hormones, treated with an entirely different set of options such as minoxidil and finasteride 5. Hair-loss treatments, ranked by the evidence, covers how those options are graded for pattern hair loss specifically. Where minoxidil fits in alopecia areata, if it has a role at all, is a separate question from its established use in pattern hair loss and shouldn't be assumed to carry over automatically. Applying a scalp sensitizer meant to provoke an immune reaction has no role in ordinary pattern hair loss, and mixing up the two conditions before starting treatment is a common, avoidable source of frustration.

Common questions

It causes an itchy, sometimes uncomfortable allergic skin reaction rather than pain in the usual sense. Redness, scaling, and itching in the treated area are expected and are actually the sign the treatment is doing what it's meant to do, not a complication to be alarmed by.

There's no fixed timeline, and response varies widely. Some people notice new growth over several months of regular treatment, while others don't respond at all. It requires an extended commitment to repeated clinic visits before anyone, patient or clinician, can tell whether it's working for that individual.

No — it's the opposite. Instead of trying to calm an allergic reaction the way you would for poison ivy or a nickel rash, this treatment deliberately maintains one at a controlled, tolerable level, on the theory that doing so redirects immune activity away from hair follicles.

That depends on the individual case and is worth asking the dermatologist managing treatment directly. Minoxidil's established role is in pattern hair loss, and whether it adds anything for alopecia areata specifically isn't the same settled question.

It's more often reserved for more extensive hair loss, or cases that haven't responded to simpler options like steroid injections, rather than being a first approach for a single small patch. How extensive the hair loss is, and what's already been tried, both factor into whether it gets offered.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to Loop In a Dermatologist About Alopecia Areata

  • —Rapid, widespread hair loss over a short period
  • —Hair loss alongside nail pitting or ridging, which can accompany alopecia areata
  • —A scalp reaction from treatment that's severe, spreading beyond the treated area, or not settling between visits
  • —Signs of infection in the treated area — increasing pain, warmth, or pus

This article is general health information, not medical advice. It cannot tell you whether topical immunotherapy is right for your alopecia areata or replace an in-person evaluation. A dermatologist experienced with this treatment is the one who can weigh it against the other options and manage the reaction it depends on.

References

  1. 1.Usatine RP, Riojas M (2010). Diagnosis and Management of Contact Dermatitis. American Family Physician. link ✓Clinical review distinguishing irritant from allergic contact dermatitis and describing allergic contact dermatitis as a sensitization-based immune reaction to a specific allergen — used here to explain the mechanism topical immunotherapy deliberately induces.
  2. 2.Argo KA, Massey RC, Luth SK, et al. (2023). Evaluation and Management of Toxicodendron Dermatitis in the Emergency Department: A Review of Current Practices. Wilderness & Environmental Medicine. doi:10.1016/j.wem.2023.03.001Poison ivy/oak/sumac dermatitis is an urushiol-triggered allergic contact dermatitis — used here as a familiar comparison for the type of reaction topical immunotherapy deliberately induces on the scalp.
  3. 3.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024). Alopecia Areata. NIH / NIAMS. link ✓Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles, causing patchy hair loss with an unpredictable course; treatments can promote regrowth but there is no cure.
  4. 4.King B, Ohyama M, Kwon O, et al. (2022). Two Phase 3 Trials of Baricitinib for Alopecia Areata. New England Journal of Medicine. doi:10.1056/NEJMoa2110343The BRAVE-AA1 and BRAVE-AA2 phase 3 trials showed oral baricitinib, a JAK1/2 inhibitor, was superior to placebo for hair regrowth in adults with severe alopecia areata — used here to show a newer, systemic treatment option alongside topical immunotherapy.
  5. 5.Adil A, Godwin M (2017). The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. PMID 28396101 ✓Minoxidil, finasteride, and low-level laser therapy promote hair growth in androgenetic (pattern) hair loss — used here to distinguish that separate condition and its treatments from alopecia areata.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library